|
DCA 2000 Plus Analyzer

Intensive management improves
glycemic control
 |
Maintaining average blood
glucose levels (120 mg/dL; 6.7 mmol/L; HbA1c 6%) lowers risk
of complications |
 |
Three- to four-times-daily blood
glucose monitoring is recommended |
 |
Establish and follow a coherent
approach of combined nutritional counseling, self-
management training, and possible hospitalization for
therapy initiation |
Reduce the risk. Monitor HbA1c levels
 |
HbA1c results monitor glucose
control over the preceding 90 to 120 days
|
 |
Complete normalization of
glycemia levels may prevent complications
|
 |
Quarterly HbA1c determination
recommended for all insulin-treated patients
|
 |
Recommendation also includes
test for microalbuminuria and others, as indicated |
Detect early stages of diabetic
nephropathy. Protect your patient from complications
 |
Intensive diabetes management
delays the onset of microalbuminuria-- an early indicator of
renal disease |
 |
Microalbumin-to-creatinine ratio
from a random urine sample is as valid an indicator of
microalbuminuria as a timed 24-hour sampling
|
 |
Persistent microalbuminuria (30
to 300 mg/day) indicates the earliest stage of diabetic
nephropathy |
 |
May also signal presence of
hypertension and the need to begin antihypertensive therapy
|
 |
Test for microalbuminuria should
be performed yearly on postpubertal patients who have had
diabetes for at least 5 years |
Specifications:
Size:
Depth: 10.7" (27.2 cm)
Width: 9.5" (24.1 cm)
Height: 9.4" (23.9 cm)
Weight:
11.0
lb. (5.0 kg)
Power:
100V to 240V (0.4A) 50/60 Hz
Ambient Operating
Temperature Range:
15°C to 32°C (59°F to 90°F)
Ambient Operating
Humidity Range:
10% to 90% (noncondensing)
$ Ordering Information
Ready to buy or learn more
about this instrument?
Please
click here
& fill out our contact page
or contact our knowledgeable sales force at
763-712-8717 / 800-745-2710 for more information.

|